Mid-Afternoon Market Update: Dow Jumps 200 Points; Aduro Biotech Shares Drop Following Announcement of Failed Phase 2b ECLIPSE Trial

By: via Benzinga
Toward the end of trading Monday, the Dow traded up 1.15 percent to 17,737.52 while the NASDAQ surged 1.35 percent to 4,781.34. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.